Prescription drug maker Eli Lilly did not err when it didn’t directly warn a patient of a drug’s risks because it had adequately informed the physician, the Washington state supreme court announced this week.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,